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Introduction: [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)
is part of the regular preoperative work-up in medically refractory epilepsy. As a
complement to visual evaluation of PET, statistical parametric maps can help in the
detection of the epileptogenic zone (EZ). However, software packages currently available
are time-consuming and little intuitive for physicians. We develop a user-friendly software
(referred as PET-analysis) for EZ localization in PET studies that allows dynamic real-time
statistical parametric analysis. To evaluate its performance, the outcome of PET-analysis
was compared with the results obtained by visual assessment and Statistical Parametric
Mapping (SPM).
Methods: Thirty patients with medically refractory epilepsy who underwent presurgical
18F-FDG PET with good post-operative outcomes were included. The 18F-FDG PET
studies were evaluated by visual assessment, with SPM8 and PET-analysis. In SPM,
parametric T-maps were thresholded at corrected p < 0.05 and cluster size k = 50
and at uncorrected p < 0.001 and k = 100 (the most used parameters in the
literature). Since PET-analysis rapidly processes different threshold combinations, T-maps
were thresholded with multiple p-value and different clusters sizes. The presurgical EZ
identified by visual assessment, SPM and PET-analysis was compared to the confirmed
EZ according to post-surgical follow-up.
Results: PET-analysis obtained 66.7% (20/30) of correctly localizing studies,
comparable to the 70.0% (21/30) achieved by visual assessment and significantly
higher (p < 0.05) than that obtained with the SPM threshold p < 0.001/k = 100,
of 36.7% (11/30). Only one study was positive, albeit non-localizing, with the SPM
threshold corrected p < 0.05/k = 50. Concordance was substantial for PET-analysis
(κ = 0.643) and visual interpretation (κ = 0.622), being fair for SPM (κ = 0.242).
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Conclusion: Compared to SPM with the fixed standard parameters, PET-analysis may
be superior in EZ localization with its easy and rapid processing of different threshold
combinations. The results of this initial proof-of-concept study validate the clinical use
of PET-analysis as a robust objective complementary tool to visual assessment for
EZ localization.
Keywords: epilepsy, functional neuroimaging, PET, SPM, parametric analysis, dynamic analysis
INTRODUCTION
Surgical resection is the potentially curative treatment option
in one third of epileptic patients who remain uncontrolled
despite polytherapy with antiepileptic drugs. Interictal
[18F]fluorodeoxyglucose (18F-FDG) positron emission
tomography (PET) has traditionally been regarded as a
complementary imaging modality in epilepsy, although some
studies have reported similar post-operative outcomes based on
PET in comparison with magnetic resonance imaging (MRI)
(1–4). However, the sensitivity of PET on visual assessment
to detect the epileptogenic zone (EZ) is moderate, being
around 80% in temporal lobe epilepsy (TLE) and 60–70% in
extratemporal lobe epilepsy (5–7). Visual interpretation of
brain PET imaging can be improved by means of objective
complementary software tools which compare each study to a
normal control group using statistical parametric analysis. This
is essential in epilepsy in which subtle hypometabolic changes
may be overlooked by the naked eye. Software packages currently
available for interpretation of brain imaging studies such as
Statistical Parametric Mapping (SPM) (8) are of generic purpose
and do not allow making real-time dynamic changes in the
level of detectability. Furthermore, faster image processing and
more intuitive software tools for physicians not familiar with
programming language are required. Taking all of the above
into account, the aim of this study was to develop, describe and
validate a dedicated user-friendly software (referred in this article
as PET-analysis) for EZ localization in 18F-FDG PET studies
in patients with medically refractory epilepsy. To evaluate its
performance, the outcome of PET-analysis was compared with
the results obtained by visual assessment and SPM processing
using the standard parameters from literature.
MATERIALS AND METHODS
Subject Selection and Characteristics
Clinical records of adult patients with medically refractory
epilepsy visited at our center for preoperative assessment were
reviewed. Candidacy for surgery depended upon the decision
of the multidisciplinary Committee of the Epilepsy Unit. The
location of the presurgical EZ was determined by consensus
during patient management meetings. Patients underwent
comprehensive presurgical assessment which consisted of
evaluation of a detailed clinical history and neurological
Abbreviations: CI95%, 95% confidence interval; EZ, epileptogenic zone; SPM,
statistical parametric mapping; TLE, temporal lobe epilepsy.
examination, complete neuropsychological evaluation,
psychiatric assessment, interictal, and ictal onset patterns in
long-term scalp video-electroencephalogram (video-EEG), MRI,
subtraction ictal-interictal single-photon emission computed
tomography (SPECT) coregistered withMRI (SISCOM) and PET
results. Invasive intracranial monitoring with subdural electrodes
was performed when the standard presurgical evaluation failed
to localize the EZ or when functional mapping of eloquent areas
was needed. Histopathological findings and at least 1-year of
follow-up after surgery according to Engel’s classification scale
were recorded. For inclusion in the study, a good to excellent
post-operative outcome (Englel scale I-II) was required.
This validation study included 30 interictal 18F-FDG PET
studies performed as part of the clinical work-up. The mean
age of the patients was 36.0 years [standard deviation (SD)
11.5 years]; 66.7% (20/30) were female and 33.3% (10/30) male.
The mean duration of epilepsy was 22.0 years (SD 13.1 years).
In 25 patients, the presurgical EZ was determined by clinical
and neuropsychologic data, video-EEG and neuroimaging, while
invasive monitoring was needed in 5 patients. The presurgical
EZ was located in the temporal lobe in 90.0% (27/30) of
patients, 56.6% (17/30) of whom had medial TLE, 16.7%
(5/30) neocortical TLE, and 16.7% (5/30) had both mesial and
lateral TLE. In the remaining 3 patients, the presurgical EZ
was located in the frontal, the parietal and the occipital lobe,
respectively. PET studies were performed in all patients whose
MRI was: (1) normal (n = 3); (2) unspecific or equivocal
(n = 11), usually doubtful dysplasias or signal alterations;
or (3) lesional (n = 16). In the latter case, PET imaging
was performed when lesions were discordant with video-EEG
(n = 1) or for delineation of the area to be resected (n = 15).
Of these 16 patients with lesional MRI, 75.0% (12/16) had
mesial temporal sclerosis, 12.5% (2/16) had areas of gliosis,
6.3% (1/16) had focal cortical dysplasia, and 6.2% (1/16) had
dysembryoplastic neuroepithelial tumor. In the pathological
study, mesial temporal sclerosis was found in 46.7% (14/30) of
patients, focal cortical dysplasia in 13.3% (4/30), both mesial
temporal sclerosis and focal cortical dysplasia in 13.3% (4/30),
gliosis in 23.3% (7/30), and pleomorphic xanthoastrocytoma
in 3.4% (1/30) of patients. The MRI of this latter patient
was the study interpreted as dysembryoplastic neuroepithelial
tumor. The post-operative seizure outcome was excellent (Engel
I) in 83.3% (25/30) of patients and good (Engel II) in 16.7%
(5/30). The mean duration of post-surgical follow-up was 3.6
years (SD 1.7 years).
The control group used in SPM and PET-analysis was the
same that was used in our previous published studies (9).
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This study was carried out in accordance with the Declaration
of Helsinki. The protocol was approved by the hospital Ethics
Committee and the need for written informed consent was
waived. STARD guidelines were followed for reporting (10).
Protocol for Imaging Acquisition and
Reconstruction
The PET studies in both the patient and control groups were
acquired and reconstructed following a routine clinical epilepsy
protocol described previously (9, 11–13). Images were acquired
in 3D mode with PET/CT equipment (Biograph; Siemens,
Erlangen, Germany). Patients were required to rest quietly in a
dimly lit room during the 40min following 18F-FDG intravenous
administration of approximately 5 MBq/kg. Subsequently,
images were acquired using a standard 11-min schedule (1min
for CT and 10min for PET). The ordered subset expectation
maximization algorithm (16 subsets and 6 iterations) was used
for PET data reconstruction with a matrix of 128 × 128 × 64
and a voxel size of 2.6 × 2.6 × 2.4 mm3. MRI studies were
acquired with a 3-Tesla unit (MagnetomTrio; Siemens, Erlangen,
Germany) using a specific epilepsy protocol.
Hypometabolic areas seen on PET studies appear as
highlighted clusters after the statistical parametric analysis.
A cluster is defined as a group of voxels (predetermined
size—k) with a value lower than a predetermined statistical
threshold. The statistical threshold (p-value) specifies the level
of variation of activity considered significant to perform the
image segmentation.
SPM Processing
The PET studies were analyzed with the SPM8 software
(Wellcome Department of Imaging Neuroscience, Institute
of Neurology, London) (8). Reconstructed PET images were
preprocessed by performing spatial normalization, proportional
scaling intensity normalization and smoothing with a Gaussian
kernel of full width at half maximum 8 × 8 × 8 mm3.
Then, a two-sample T-Student test was carried out between
the preprocessed PET image of each patient and the control
database. To reduce background activity, only voxels with a
value >30% of the maximum value (threshold mask of 0.3) were
used in the statistical analysis. Statistical parametric maps were
thresholded at p< 0.05 and cluster size k= 50, when family-wise
error correction for multiple comparisons was performed, and at
p < 0.001 and k = 100 otherwise. These threshold combinations
were chosen because of their extensive use in previous studies
(6, 14–16, 21, 22).
PET-Analysis Processing
PET-analysis is a new software based on the same methodology
as the one carried out when SPM is used to perform a voxel-
by-voxel statistical analysis. We introduced somemethodological
improvements which we thought were necessary for PET studies
in the field of epilepsy based on our daily clinical experience.
First, the PET studies were spatially normalized into a standard
space with the aid of a previously created 18F-FDG PET template
image (9) using a 12-parameter affine transformation followed
by a non-linear deformation as in SPM normalization. Spatial
normalization included linear and non-linear deformations and
it was carried out with Elastix (14). Second, spatially normalized
PET studies were intensity normalized in order to remove
global intensity differences in cerebral metabolism between
subjects (15). Intensity normalization was performed following
a method that fits a parabola around the maximum value of
the quotient distribution between images to overcome the bias
in the normalization factor that can occur when the factor is
calculated as the quotient between the total counts in the patient
and the control studies. Third, the PET studies obtained in
the previous step were smoothed with a Gaussian filter (full
width at half maximum = 8 × 8 × 8 mm3) in order to
reduce noise. Finally, a two sample T-Student test was performed
in which one group consisted of the preprocessed PET study
and the other group included the control studies, both groups
after following the three steps described above. As seizures
occur in the gray matter, a mask on which non-zero values
were located only in the gray matter regions of the image
was used in this comparison. Then, the parametric T-maps
were thresholded with multiple p-values (ranging from 0.05 to
0.0001) and minimum clusters size (ranging from 50 to 200 k)
combinations by sliding two scrollbars, as this new application
rapidly processes different threshold combinations in the same
workflow session (Figure 1). Segmentation parameters can be
rapidly switched simply by sliding any of the two scrollbars or
using the up/down arrowheads representing p and k values. PET-
analysis facilitates a more dynamic segmentation of images by
allowing observers to modulate thresholds in real time, being
more restrictive or liberal depending on the results of previous
chosen thresholds.
Image Interpretation
Two experienced nuclear medicine physicians, who had no
knowledge of the patients’ clinical data, independently evaluated
the PET studies and provided a presurgical EZ (hemispheric and
sublobar location) for each set of PET imaging modalities (visual
interpretation, SPM, and PET-analysis) obtained per patient.
Processed PET images where corregistered with MRI following
the same transformation and an automatic anatomic labeling
template was used to determine the location of hypometabolic
areas, represented as clusters (16). PET studies in which a
hypometabolic area within the cerebral cortex was observed by
visual interpretation or a cluster after SPM and PET-analysis
processing were labeled as “positive studies.” When a unique
cluster appeared after the analysis with SPM and PET-analysis,
this area was defined as the presurgical EZ. When more than
one cluster appeared after image processing, the definition of the
presurgical EZ was based on both the statistical significance and
the cluster size; the biggest cluster and with the highest statistical
significance was considered as the presurgical EZ. Areas of
decreased metabolism located outside the cerebral cortex or at
the interhemispheric region were excluded. Any discrepancy in
observer assessment was resolved by consensus. The presurgical
EZ with side and sublobar concordance with the post-surgically
confirmed EZ were considered as “correctly localizing studies.”
The observers also recorded for each patient evaluation the
number of clusters which were present in SPM and PET-analysis
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FIGURE 1 | User interface of PET-analysis. Segmentation parameters can be rapidly switched simply by sliding any of the two scrollbars or using the up/down
arrowheads representing p and k values. PET-analysis facilitates a more dynamic segmentation of images by allowing observers to modulate thresholds in real time,
being more restrictive or liberal depending on the results of previous chosen thresholds.
and the level of confidence with which the presurgical EZ for each
study (high, medium or low confidence) was assigned.
MRI studies were visually interpreted by a senior
neuroradiologist specialized in epilepsy.
Analysis and Statistics
The proportion of positive and correctly localizing studies by
visual assessment and after SPM and PET-analysis processing was
compared with the McNemar’s test. The proportion of positive
and correctly localizing studies by MRI were also calculated.
The concordance between the presurgical EZ according to the
different techniques and the post-surgical EZ was evaluated using
the kappa index (κ) and its 95% confidence interval (CI95%).
This concordance was considered as slight with κ > 0 and≤0.20,
fair with κ > 0.21 and κ ≤ 0.40, moderate with κ > 0.41 and κ ≤
0.60, substantial with κ > 0.61 and κ ≤ 0.80, and excellent with
κ > 0.81. The mean value of the clusters obtained with SPM and
PET-analysis was assessed. The proportion of correctly localizing
PET studies was compared with the number of clusters and the
level of confidence using the Chi2 test. The number of clusters
and the level of confidence were compared with the analysis of
variance (ANOVA). Differences were considered to be significant
with a p< 0.05. Statistical analysis was performed with MedCalc
Statistical Software version 16.2.1.
RESULTS
Positive and Localizing Studies
Table 1 shows PET and MRI findings, histopathology and
surgical outcome of each of the 30 patients included. Table 2
shows the number and percentage of positive, negative, correctly
localizing, and non-localizing PET studies obtained after visual
assessment, SPM, PET-analysis, and MRI. Hypometabolic areas
were detected by visual assessment in 28/30 (93.3%) of PET
studies, and the presurgical EZ was correctly localized in 21/30
(70.0%) of patients. PET-analysis achieved comparable results
with 30/30 (100.0%) of positive and 20/30 (66.7%) correctly
localizing studies. The SPM threshold p < 0.001/k = 100
obtained inferior results with 18/30 (60.0%) of positive and
11/30 (36.7%) correctly localizing studies. Statistically significant
differences were found between this SPM threshold and the
results achieved by visual assessment (p = 0.0309) and PET-
analysis (p = 0.0117). The SPM threshold p < 0.05/k = 50
with family-wise error correction was too restrictive and only
one study was positive, albeit non-localizing, after analysis
(Table 1, patient 15). The 16/30 (53.3%) MRI were correctly
localizing studies.
Four patients (13.3%) with negative or incorrectly localizing
PET by visual assessment and non-lesional by MRI had
correctly localizing PET studies with post-processing
techniques (Table 1, patients 19, 22, 27, and 30), one of
them only with PET-analysis (patient 19). On the other
hand, two patients (6.7%) who had correctly localizing
PET by visual interpretation and MRI (Table 1, patients 11
and 13) were negative in SPM-analysis and had incorrectly
localizing studies with PET-analysis. Among three patients
(10.0%) in whom no SPM threshold combination, PET-
analysis, or MRI showed any remarkable finding (Table 1,
patients 17, 20, and 29), two were positive, although
non-localizing, by visual assessment (patients 17 and 20)
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TABLE 1 | PET and MRI findings, histopathology and surgical outcome.
No. PEZ Visual SPM1 SPM2 PET-a MRI Hp. Engel
1 R/MT R/LT Neg R/LT R/MT R/MTS MTS I
2 L/MT L/MT Neg L/LT L/MT L/MTS MTS I
3 L/MT L/MT Neg L/MT L/MT L/MTS MTS I
4 L/MT L/MT Neg L/LT L/MT L/MTS MTS I
5 L/MLT L/LT Neg Neg L/MT L/MTS FCDI+MTS I
6 L/MT L/MT Neg L/MT L/MT L/MTS FCDIIA I
7 R/MT R/MT Neg Neg R/MT R/MTS MTS I
8 R/MT R/LT Neg R/MT R/MT R/MTS MTS I
9 L/MT L/MT Neg Neg L/MT L/MTS MTS I
10 R/MT R/MT Neg R/MT R/MT R/MTS MTS II
11 L/MT L/MT Neg Neg L/LT L/MTS Gliosis I
12 R/MT R/MT Neg R/MT R/MT R/MTS MTS I
13 L/LT L/LT Neg Neg R/I L/LT DNET Xanthoastr. II
14 L/LT L/LT Neg L/LT L/LT L/LT Gliosis Gliosis I
15 R/P R/P R/O R/O R/P R/P FCD FCDII I
16 L/O L/O Neg Neg L/O L/O Gliosis Gliosis I
17 R/MT R/LT Neg R/LT R/LT Non-L MTS I
18 R/MLT R/MT Neg Neg R/MT Non-L FCDIIA+MTS I
19 L/MLT R/MT Neg Neg L/MT Non-L FCDIIA+MTS I
20 R/MT R/LT Neg R/LT L/LT Non-L MTS II
21 R/MT R/MT Neg Neg L/MT Non-L Gliosis I
22 R/MT R/LT Neg R/MT R/MT Non-L MTS I
23 R/MT R/MT Neg Neg R/MT Non-L MTS II
24 L/F L/F Neg L/F L/F Non-L FCDIIA I
25 R/LT R/LT Neg Neg L/F Non-L FCDI I
26 R/MLT R/LT Neg R/LT L/LT Non-L Gliosis I
27 L/MT L/LT Neg L/MT L/MT Non-L MTS I
28 R/MLT R/MT Neg Neg L/LT Non-L FCDIIA+MTS II
29 R/LT Neg Neg L/P L/LT Non-L Gliosis I
30 R/LT Neg Neg R/LT R/LT Non-L Gliosis I
No.,Patient number; PEZ, Post-surgically confirmed epileptogenic zone; Visual, PET visual assessment; SPM1, corrected p < 0.05 and k = 50; SPM2, uncorrected p < 0.001 and
k = 100; PET-a, PET-analysis; Hp., Histopathology; F, Female; M, Male; R, Right; L, Left; MT, Mesial temporal; LT, Temporal; MLT, Mesial and lateral temporal; P, Parietal; O, Occipital;
F, Frontal; I, Insula; Neg, Negative; Non-L, Non-lesional MRI (unspecific and negative studies); MTS, Mesial temporal sclerosis; DNET, dysembryoplastic neuroepithelial tumor; FCD,
Focal cortical dysplasia; Xanthoastr., Pleomorphic xanthoastrocytoma.
and the other patient also had a visually negative PET
study (patient 29).
Concordance With Post-surgical EZ
Table 3 shows the concordance between visual assessment, SPM
and PET-analysis in comparison to the post-surgical EZ. The
concordance was substantial for PET-analysis (κ = 0.643, CI 95%
0.439, 0.847) and visual interpretation (κ = 0.622, CI 95% 0.367,
0.877), while being fair for the SPM threshold p< 0.001/k= 100
(κ = 0.242, CI 95% 0.028, 0,455) and moderate for MRI
(κ = 0.520, CI 95% 0.268, 0.772).
Number of Clusters and Level of
Confidence
The only study which was positive with the SPM threshold
p < 0.05/k = 50 had one cluster, and the observers assigned the
presurgical EZ with a high level of confidence. A mean of 2.6
clusters (SD 2.4 clusters) was observed with the SPM threshold
p< 0.001/k= 100. The level of observer confidence for assigning
the presurgical EZ with this SPM threshold combination was
high in 10/30 (33.3%) studies, medium in 6/30 (20%), and low
in 2/30 (6.7%) studies. Statistically significant differences were
found between the proportion of correctly localizing studies vs.
the number of clusters found in the analysis (p = 0.041) and the
observer level of confidence (p= 0.024) with this SPM threshold
p< 0.001/k= 100.
A mean of 3.2 clusters was observed with PET-analysis (SD
1.3 clusters). The level of confidence with which the observers
assigned the presurgical EZ with PET-analysis was high in 13/30
(43.3%) studies, medium in 13/30 (43.3%), and low in 4/30
(13.4%) studies. There were statistically significant differences
between the number of clusters and the proportion of correctly
localizing studies (p = 0.043) and observer level of confidence
(p= 0.038) in PET-analysis.
DISCUSSION
Assessment of medically refractory epilepsy is challenging and
objective tools are needed to complement the interpretation
of neuroimaging studies on visual assessment. The results
Frontiers in Neurology | www.frontiersin.org 5 April 2019 | Volume 10 | Article 380
Mayoral et al. PET Dynamic Analysis for Epilepsy
TABLE 2 | Number and percentage of positive, negative, correctly localizing, and
non-localizing PET studies by visual assessment, SPM and PET-analysis and MRI.
Positive (%) Negative (%) Localizing
(%)
Non-localizing
(%)
Visual 28/30 (93.3) 2/30 (6.7) 21/30 (70.0) 7/30 (23.3)
SPM1 1/30 (3.3) 29/30 (96.7) 0/30 (0.0) 30/30 (100.0)
SPM2 18/30 (60.0) 12/30 (40.0) 11/30 (36.7) 7/30 (23.3)
PET-analysis 30/30 (100.0) 0/30 (0.0) 20/30 (66.7) 10/30 (33.3)
MRI 16/30 (53.3) 14/30 (46.7)* 16/30 (53.3) 0/30 (0.0)
*Non-lesional MRI studies are shown in this square (unspecific and negative studies).
Visual, PET visual assessment; SPM1, corrected p< 0.05 and k= 50; SPM2, uncorrected
p < 0.001 and k = 100.
TABLE 3 | Concordance between visual assessment, SPM, and PET-analysis
compared to the post-surgical EZ.
Kappa index CI95%
Visual 0.622 0.367,0.877
SPMa 0.242 0.028,0.455
PET-analysis 0.643 0.439,0.847
MRI 0.520 0.268,0.772
aSPM thresholded at uncorrected p < 0.001 and k = 100.
Visual, PET visual assessment.
of the present study have validated PET-analysis as a
new software to objectively localize the post-surgically
confirmed EZ, in a series of 30 operated patients who
underwent an 18F-FDG PET study in the presurgical
evaluation of drug-resistant epilepsy. PET-analysis was
correctly localizing in two thirds of studies with substantial
concordance with the post-surgical EZ, being comparable to
the results achieved by visual assessment and significantly
higher than the rate of correctly localizing results obtained
with SPM, which showed fair concordance with the
post-surgical EZ.
The concept of this new software PET-analysis arose from
the need for an application which could rapidly process
different threshold combinations in the same workflow session,
simply by sliding two scrollbars representing a wide spectrum
of values in terms of statistical significance and cluster
sizes. PET-analysis facilitates a more dynamic segmentation
of images by allowing observers to modulate uncorrected
thresholds in real time, being more restrictive or liberal
depending on the results of previous chosen thresholds.
Moreover, PET-analysis is a SPM-independent application based
on open-source software programs with a more intuitive
graphical user interface for physicians not familiar with
programming language.
The overall utility of SPM in PET studies of epilepsy is
controversial; while some studies have shown that SPM has a
tendency to improve visual assessment (17–20), other articles
have reported similar (21–23) or even worse results (4, 24).
In our study, visual assessment was superior to SPM with
70.0% (21/30) vs. 36.7% (11/30) of correctly localizing studies,
respectively. However, these results may be attributable to the
fact that only two thresholds were used in SPM, one of which
was too restrictive, and the performance of SPM is dependent
on the thresholds chosen for its analysis. Earlier publications in
the literature, in both pediatric and adult patients, used fixed
sizes of contiguous voxels for different p-values (6, 18–20) or
exclusively one threshold combination (4, 21–23), which might
not be suitable for all imaging studies. In the present study in
which a new software was validated, we decided to apply the
most common SPM thresholds used in the literature, which are a
corrected p-value of p< 0.05, an uncorrected p-value of p< 0.001
and cluster sizes of 50–100 voxels, respectively (6, 17–20, 24, 25).
However, as reported in our previous article (9), the greatest
sensitivity and specificity for larger spatial extent of voxels tends
to be achievedmore significant p-values because multiple clusters
might appear with less significant p-values. Inversely, for stricter
p-values, smaller cluster sizes should be chosen since otherwise
the hypometabolic regions would not likely survive the statistical
analysis. According to our previous study, the best thresholds for
SPM were an uncorrected p-value of p< 0.001 with k= 100 and
an uncorrected p-value of p< 0.005 with k= 200. It would seem
that the best approach in epilepsy would be to use uncorrected
thresholds as the lesions in this disorder are usually small-sized
areas of decreasedmetabolismwhich do not survive the statistical
analysis when using corrected thresholds. Another remarkable
point that should be mentioned is that some previous studies
only included pediatric patients (19, 24, 25) and other articles
are more heterogeneous and included mostly adult patients but
also few children (6, 17, 18, 20). Although these articles used
similar or even the same thresholds for SPM analysis, as 18F-FDG
brain metabolism in children may differ from adults, it should be
analyzed in further studies if different thresholds should be used
depending on the age of the patient.
The performance of PET-analysis in this validation study
was superior to that of SPM (Figure 2), with 66.7% (20/30)
vs. 36.7% (11/30) of correctly localizing studies and substantial
to fair concordance with post-surgical EZ, respectively. These
better results could be ascribed to optimized thresholding in real
time and spatial normalization. On the other hand, PET-analysis
results were similar to visual assessment, although PET-analysis
obtained a slightly superior concordance with the post-surgical
EZ (κ = 0.643 vs. κ = 0.622, respectively). In accordance with
the results of Zhu et al. (25), we believe that objective post-
processing applications are complementary to visual assessment.
These authors reported that visual assessment combined with
SPM analysis detected more patients with abnormal glucose
metabolism in PET studies compared to visual assessment
alone. In our study, four patients (13.3%) who had negative or
incorrectly localizing PET by visual assessment and non-lesional
MRI (Table 1, patients 19, 22, 27, and 30) had correctly localizing
PET studies with post-processing techniques, one of which
(patient 19) was only obtained with PET-analysis. However, on
the other hand, two patients (6.7%) who had correctly localizing
PET by visual interpretation andMRI (Table 1, patients 9, 11, and
13) had incorrectly localizing studies with PET-analysis.
It is also noteworthy that despite SPM interpretation being
considered user-independent, various significant hypometabolic
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FIGURE 2 | A representative case of the utility of PET-analysis. Patient with a 34-year history of medically refractory epilepsy with weekly seizures (Table 2, patient
16). Video-EEG showed epileptiform activity in the left occipital region. MRI depicted a focal lesion in the left occipital lobe (A,B) which was suggestive of a small area
of residual encephalomalacia or secondly, cortical dysplasia with subcortical extension (MRI sequences from up to down: coronal FLAIR and axial contrast-enhanced
T1-weighted). On suspicion of dysplasia, a PET study was requested to plan the extent of surgical resection, and a left occipital hypometabolism was seen on visual
assessment (C,D). No hypometabolic areas were present at any threshold in SPM analysis, although a left occipital hypometabolism was seen in the SPM-normalized
images (E,F), which was more evident in the PET-analysis-normalized images (G,H). A left occipital hypometabolic area appeared on PET-analysis (thresholds shown:
p = 0.008 and k = 200), corresponding with the occipital lesion on corregistered images with T1-weighted MRI (I,J). The lesion was surgically resected and the
pathology study diagnosed a chronic hemorrhagic necrosis foci with gliosis. Fifty-nine months years after surgery the patient is completely seizure-free (Engel I).
areas may appear after analysis, especially when liberal thresholds
are used, which may diminish observer confidence to determine
the presurgical EZ. PET-analysis thresholds can be dynamically
modulated in real time so that observers can apply more
restrictive thresholds in order to decrease the number of
clusters and, thus, increase their confidence when assigning
the presurgical EZ among other hypometabolic areas. In other
words, by decreasing the number of clusters the error range
also reduces and, hence, the reliability of the test increases.
Indeed, we found that the numbers of clusters in the PET-
analysis correlated with the level of confidence and the rate
of correctly localizing studies. Although the mean number of
clusters obtained with PET-analysis was slightly higher than that
of SPM (3.2 vs. 2.6 cluster per study), there was an increase in
observer confidence with PET-analysis, with a high and medium
level of confidence in 13/30 (43.3%) and 13/30 (43.3%) studies,
respectively, vs. 10/30 (33.3%) and 6/30 (20%) with SPM. This
higher level of confidence with PET-analysis could be explained
by observers being able to modulate segmentation parameters
depending on the hypometabolic areas seen with previously
used thresholds, and thereafter choosing more restrictive or
liberal p-values and cluster sizes. According to the results of
this study and also to our clinical experience, the best approach
in epilepsy is to use multiple uncorrected thresholds as some
lesions are small-sized areas of decreased metabolism which
are eliminated when using corrected thresholds. SPM is a
generic program designed for the analysis of brain imaging
data and PET-analysis was created to specifically process
PET images from epileptic patients. It is also important to
mention that the statistical test, which is a T-Student test
comparison, is only performed once per patient and thus the
use of a correction for multiple tests is not applicable in
this situation.
This study had some limitations, the first being a selection
bias inherent to the retrospective study design in a very
selected group of patients. We needed cases with a confirmed
lesion culprit of epilepsy and for this reason we could only
include operated patients who were seizure free during a
long follow-up, as only under these circumstances the EZ
can be defined. Another limitation implicit in a parametric
analysis is that it is very possible that 18F-FDG brain uptake
of an individual patient may differ from the control group
in a number of brain areas, related to the EZ or not.
To validate this new application, most of the PET studies
included had evident presurgical EZ on visual assessment to
confirm that PET-analysis was able to detect these unambiguous
hypometabolisms. It remains to be determined if PET-
analysis is capable of prospectively detecting more subtle
hypometabolisms that could be hidden to the naked eye in
a non-surgically intervened group of patients, who are more
representative of the clinical heterogeneity found in routine
practice. Objective tools like PET-analysis could help the
neurologist and the neurosurgeon in identifying the EZ but have
to be considered together with other imaging modalities and
additional patient data such as the semiology of the epileptic
seizures and video-EEG, all of which should be performed as
Frontiers in Neurology | www.frontiersin.org 7 April 2019 | Volume 10 | Article 380
Mayoral et al. PET Dynamic Analysis for Epilepsy
part of the regular preoperative work-up and evaluated in a
multidisciplinary committee.
In conclusion, PET-analysis is a robust in-house application
for EZ localization in PET studies of patients with medically
refractory epilepsy. This new software showed a better
performance than SPM with the fixed standard parameters,
as it can easily and rapidly process different thresholds of image
segmentation which can be switched in real time. It also has
an intuitive graphical user interface making it user-friendly
for physicians. Although this software has to be tested in a
bigger and non-selected group of patients, the results of the
present proof-of-concept study validate the use of PET-analysis
as an objective complementary tool to visual assessment for
EZ localization.
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